Literature DB >> 11241356

Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells.

Y Inagaki1, M Mamura, Y Kanamaru, P Greenwel, T Nemoto, K Takehara, P Ten Dijke, A Nakao.   

Abstract

Hepatic stellate cells (HSC) are the main producers of type I collagen in fibrotic liver, and transforming growth factor-beta (TGF-beta) plays critical roles in stimulating collagen gene expression in the cells mainly at the level of transcription. We have previously identified an upstream sequence of alpha2(I) collagen gene (COL1A2) that is essential for its basal and TGF-beta-stimulated transcription in skin fibroblasts and HSC. We designated this region the TGF-beta-responsive element (TbRE). Recently Smad3, an intracellular mediator of TGF-beta signal transduction, has been shown to bind to the TbRE and stimulate COL1A2 transcription when overexpressed in skin fibroblasts. In the present study, we demonstrate increased transcription of COL1A2 and plasminogen activator inhibitor-1 (PAI-1) genes and low response to TGF-beta in an activated HSC clone derived from a cirrhotic liver. Western blot analyses indicated constitutive phosphorylation of Smad3 in the cells. Immunofluorescence studies revealed that, in contrast to Smad2 that translocated from the cytoplasm to the nucleus upon TGF-beta treatment, Smad3 and Smad4 were present in the nucleus irrespective of ligand stimulation. Increased COL1A2 and PAI-1 gene transcription in the cells was not affected by overexpression of inhibitory Smad7. Altogether, the results correlate abnormality in TGF-beta/Smad signaling with pathologically accelerated collagen gene transcription in activated HSC. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11241356     DOI: 10.1002/1097-4652(2001)9999:9999<00::AID-JCP1059>3.0.CO;2-S

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  26 in total

1.  Overexpression of hepatic plasminogen activator inhibitor type 1 mRNA in rabbits with fatty liver.

Authors:  J G Fan; L H Chen; Z J Xu; M D Zeng
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

2.  PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells.

Authors:  Caiyan Zhao; Wei Chen; Liu Yang; Lihong Chen; Stephen A Stimpson; Anna Mae Diehl
Journal:  Biochem Biophys Res Commun       Date:  2006-09-22       Impact factor: 3.575

Review 3.  Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis.

Authors:  Y Inagaki; I Okazaki
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

4.  Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene.

Authors:  Tawin Iempridee; Shreyasi Das; Iris Xu; Janet E Mertz
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

5.  Inhibition of acidic sphingomyelinase reduces established hepatic fibrosis in mice.

Authors:  Ralph C Quillin; Gregory C Wilson; Hiroyuki Nojima; Christopher M Freeman; Jiang Wang; Rebecca M Schuster; John A Blanchard; Michael J Edwards; Chandrashekhar R Gandhi; Erich Gulbins; Alex B Lentsch
Journal:  Hepatol Res       Date:  2014-06-04       Impact factor: 4.288

6.  Transforming growth factor beta-activated kinase 1 is a key mediator of ovine follicle-stimulating hormone beta-subunit expression.

Authors:  Nedal Safwat; Jun Ninomiya-Tsuji; A Jesse Gore; William L Miller
Journal:  Endocrinology       Date:  2005-08-04       Impact factor: 4.736

7.  The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease.

Authors:  Peter J Lewindon; Tamara N Pereira; Anita C Hoskins; Kim R Bridle; Richard M Williamson; Ross W Shepherd; Grant A Ramm
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

8.  Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment.

Authors:  Vivian Barry-Hamilton; Rhyannon Spangler; Derek Marshall; Scott McCauley; Hector M Rodriguez; Miho Oyasu; Amanda Mikels; Maria Vaysberg; Haben Ghermazien; Carol Wai; Carlos A Garcia; Arleene C Velayo; Brett Jorgensen; Donna Biermann; Daniel Tsai; Jennifer Green; Shelly Zaffryar-Eilot; Alison Holzer; Scott Ogg; Dung Thai; Gera Neufeld; Peter Van Vlasselaer; Victoria Smith
Journal:  Nat Med       Date:  2010-09-05       Impact factor: 53.440

9.  Expression and location of Smad2, 4 mRNAs during and after liver fibrogenesis of rats.

Authors:  Yang Liu; Li-Feng Wang; Hai-Feng Zou; Xiao-Yan Song; Hua-Feng Xu; Ping Lin; Hai-Hong Zheng; Xiao-Guang Yu
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

10.  Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling.

Authors:  Anita Pathil; Jan Mueller; Johannes M Ludwig; Jiliang Wang; Arne Warth; Walee Chamulitrat; Wolfgang Stremmel
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.